PROGEN — Prostatype Genomics AB Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapSucker Stock

Annual balance sheet for Prostatype Genomics AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	SAS	SAS	SAS	SAS	SAS
Status:	Final	Final	Final	Final	Final
Cash
Short Term Investments
Cash and Short Term Investments	15.9	20.3	11.5	2.68	9.42
Net Total Accounts Receivable
Net Total Receivables	0.915	0.65	2.16	22.7	1.64
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	17.5	21.6	14.2	25.9	11.8
Net Property, Plant And Equipment	0.028	0.014	0.004	0.06	0.312
Net Intangible Assets
Long Term Investments
Total Assets	33.7	40.2	31	49.2	42
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	4.31	3.43	4.33	24.5	8.5
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	5.37	4.3	4.8	24.5	8.5
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	28.3	35.9	26.2	24.7	33.5
Total Liabilities & Shareholders' Equity	33.7	40.2	31	49.2	42
Total Common Shares Outstanding